Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-20-003004
Filing Date
2020-05-22
Accepted
2020-05-22 15:52:19
Documents
56
Period of Report
2018-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sigo_10q.htm 10-Q 370578
2 CERTIFICATION sigo_ex311.htm EX-31.1 7685
3 CERTIFICATION sigo_ex321.htm EX-32.1 3321
  Complete submission text file 0001477932-20-003004.txt   2725655

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT sigo-20180731.xml EX-101.INS 425054
5 XBRL TAXONOMY EXTENSION SCHEMA sigo-20180731.xsd EX-101.SCH 43409
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE sigo-20180731_lab.xml EX-101.LAB 261130
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sigo-20180731_cal.xml EX-101.CAL 32791
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sigo-20180731_pre.xml EX-101.PRE 244944
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sigo-20180731_def.xml EX-101.DEF 132304
Mailing Address 20420 SPENCE ROAD SALINAS CA 93908
Business Address 20420 SPENCE ROAD SALINAS CA 93908 4242396230
Sunset Island Group (Filer) CIK: 0001689066 (see all company filings)

EIN.: 473278534 | State of Incorp.: CO | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 333-214643 | Film No.: 20905691
SIC: 2834 Pharmaceutical Preparations